Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA290142
Max Phase: Preclinical
Molecular Formula: C43H53N7O9S
Molecular Weight: 844.00
Molecule Type: Small molecule
Associated Items:
ID: ALA290142
Max Phase: Preclinical
Molecular Formula: C43H53N7O9S
Molecular Weight: 844.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C(=O)[C@H](CCCCNC(=O)/C=C/c1cccs1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C43H53N7O9S/c1-43(2,3)59-42(58)49-34(24-28-26-46-31-17-9-8-16-30(28)31)39(55)47-32(18-10-11-21-45-36(51)20-19-29-15-12-22-60-29)41(57)50(4)35(25-37(52)53)40(56)48-33(38(44)54)23-27-13-6-5-7-14-27/h5-9,12-17,19-20,22,26,32-35,46H,10-11,18,21,23-25H2,1-4H3,(H2,44,54)(H,45,51)(H,47,55)(H,48,56)(H,49,58)(H,52,53)/b20-19+/t32-,33-,34?,35-/m0/s1
Standard InChI Key: PFDXGRUVVNQAQW-AAYKEFHDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 844.00 | Molecular Weight (Monoisotopic): 843.3625 | AlogP: 3.66 | #Rotatable Bonds: 21 |
Polar Surface Area: 242.12 | Molecular Species: ACID | HBA: 9 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.10 | CX Basic pKa: | CX LogP: 3.45 | CX LogD: 0.35 |
Aromatic Rings: 4 | Heavy Atoms: 60 | QED Weighted: 0.05 | Np Likeness Score: -0.42 |
1. Bennett MJ, Nikkel AL, Bianchi BR, Miller TR, Bednarz L, Witte DG, Stashko M, Wang SS, Gore PA, Asin KE.. (1994) CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue., 37 (11): [PMID:8201591] [10.1021/jm00037a006] |
Source(1):